These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8759075)

  • 21. A preliminary study on the therapeutic effects of a calcium antagonist (diltiazem) on primary congestive cardiomyopathy. A clinical survey of 15 cases.
    Huang DX; Ding ZC; Chen KL; Li HE
    Jpn Heart J; 1988 May; 29(3):325-33. PubMed ID: 3172476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy.
    Moruzzi P; Doria E; Agostoni PG; Capacchione V; Sganzerla P
    Am J Cardiol; 1994 Feb; 73(5):374-8. PubMed ID: 8109552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
    Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
    Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy].
    Huang J; Zheng Z; Hu SS; Yang YJ; Zhao H; Song LF; Song YH; Zhu J; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1005-8. PubMed ID: 17288765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy.
    Andersson B; Caidahl K; di Lenarda A; Warren SE; Goss F; Waldenström A; Persson S; Wallentin I; Hjalmarson A; Waagstein F
    Circulation; 1996 Aug; 94(4):673-82. PubMed ID: 8772687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of right ventricular function and interstitial fibrosis in idiopathic dilated cardiomyopathy: hemodynamic correlates and prognostic value.
    La Vecchia L; Bedogni F; Castellani A; Martini M; Paccanaro M; Sartori M; Bozzola L; Bevilacqua P; Vincenzi M
    G Ital Cardiol; 1998 May; 28(5):513-23. PubMed ID: 9646066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of exercise and nitroprusside on left ventricular ejection dynamics in idiopathic dilated cardiomyopathy.
    Kussmaul WG; Kleaveland JP; Martin JL; Hirshfeld JW; Laskey WK
    Am J Cardiol; 1987 Mar; 59(6):647-55. PubMed ID: 3825907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficient acceleration of left ventricular relaxation during exercise after heart transplantation.
    Paulus WJ; Bronzwaer JG; Felice H; Kishan N; Wellens F
    Circulation; 1992 Oct; 86(4):1175-85. PubMed ID: 1382887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.
    Singh TP; Sleeper LA; Lipshultz S; Cinar A; Canter C; Webber SA; Bernstein D; Pahl E; Alvarez JA; Wilkinson JD; Towbin JA; Colan SD
    Circ Heart Fail; 2009 Nov; 2(6):591-8. PubMed ID: 19919984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current perspectives of partial left ventriculectomy in the treatment of dilated cardiomyopathy.
    Moreira LF; Stolf NA; de Lourdes Higuchi M; Bacal F; Bocchi EA; Oliveira SA
    Eur J Cardiothorac Surg; 2001 Jan; 19(1):54-60. PubMed ID: 11163561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic changes due to afterload reduction as a predictor of exercise capacity in patients with dilated cardiomyopathy.
    Hashimoto M; Okamoto M; Yamagata T; Yamane T; Morichika N; Tsuchioka Y; Matsuura H; Kajiyama G
    Intern Med; 1992 Mar; 31(3):344-8. PubMed ID: 1611185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D; De Maria R; Masi S; Gallopin M; Pisani P; Pardini S; Gavazzi A; L'abbate A; Parodi O
    Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.